Sex-Specific Medicine in Human Physiopathology: Comparison
Please note this is a comparison between Version 3 by Jessie Wu and Version 2 by Jessie Wu.

A prodigious increment of scientific evidence in both preclinical and clinical studies is narrowing a major gap in knowledge regarding sex-specific biological responses observed in numerous branches of clinical practices. Some paradigmatic examples include neurodegenerative and mental disorders, immune-related disorders such as pathogenic infections and autoimmune diseases, oncologic conditions, and cardiovascular morbidities. The male-to-female proportion in a population is expressed as sex ratio and varies eminently with respect to the pathophysiology, natural history, incidence, prevalence, and mortality rates.

  • gender medicine
Please wait, diff process is still running!

References

  1. Holst, J.P.; Soldin, O.P.; Guo, T.; Soldin, S.J. Steroid hormones: Relevance and measurement in the clinical laboratory. Clin. Lab. Med. 2004, 24, 105–118.
  2. Moraga-Amaro, R.; Van Waarde, A.; Doorduin, J.; De Vries, E.F.J. Sex steroid hormones and brain function: PET imaging as a tool for research. J. Neuroendocr. 2018, 30, e12565.
  3. Sanderson, J.T. The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals. Toxicol. Sci. 2006, 94, 3–21.
  4. Hiort, O.; Holterhus, P.M. The molecular basis of male sexual differentiation. Eur. J. Endocrinol. 2000, 142, 101–110.
  5. Veldhuijzen, D.S.; Keaser, M.L.; Traub, D.S.; Zhuo, J.; Gullapalli, R.P.; Greenspan, J.D. The role of circulating sex hormones in menstrual cycle–dependent modulation of pain-related brain activation. Pain 2013, 154, 548–559.
  6. Brambilla, D.; Matsumoto, A.M.; Araujo, A.B.; McKinlay, J.B. The Effect of Diurnal Variation on Clinical Measurement of Serum Testosterone and Other Sex Hormone Levels in Men. J. Clin. Endocrinol. Metab. 2009, 94, 907–913.
  7. Wittert, G. The relationship between sleep disorders and testosterone in men. Asian J. Androl. 2014, 16, 262–265.
  8. Schipper, H.M. The Impact of Gonadal Hormones on the Expression of Human Neurological Disorders. Neuroendocrinology 2015, 103, 417–431.
  9. Reddy, D.S. Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 2010, 186, 113–137.
  10. Reddy, D.S.; Bakshi, K. Neurosteroids: Biosynthesis, molecular mechanisms, and neurophysiological functions in the human brain. In Hormonal Signaling in Biology and Medicine; Elsevier Inc.: Amsterdam, The Netherlands, 2020; pp. 69–82.
  11. Bhargava, A.; Arnold, A.P.; Bangasser, D.A.; Denton, K.M.; Gupta, A.; Krause, L.M.H.; Mayer, E.A.; McCarthy, M.; Miller, W.L.; Raznahan, A.; et al. Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement. Endocr. Rev. 2021, 42, 219–258.
  12. Rey, R.; Josso, N.; Racine, C. Sexual Differentiation; MDText.com Inc.: South Dartmouth, MA, USA, 2020.
  13. Maekawa, F.; Tsukahara, S.; Kawashima, T.; Nohara, K.; Ohki-Hamazaki, H. The mechanisms underlying sexual differentiation of behavior and physiology in mammals and birds: Relative contributions of sex steroids and sex chromosomes. Front. Neurosci. 2014, 8, 242.
  14. Arnold, A.P. Sex chromosomes and brain gender. Nat. Rev. Neurosci. 2004, 5, 701–708.
  15. Savic, I.; Garcia-Falgueras, A.; Swaab, D.F. Sexual differentiation of the human brain in relation to gender identity and sexual orientation. Funct. Neurol. 2010, 186, 41–62.
  16. Warfvinge, K.; Krause, D.N.; Maddahi, A. Estrogen receptors α, β and GPER in the CNS and trigeminal system—Molecular and functional aspects. J. Headache Pain 2020, 21, 131.
  17. Delchev, S.; Georgieva, K. Cellular and Molecular Mechanisms of the Effects of Sex Hormones on the Nervous System, Sex Hormones in Neurodegenerative Processes and Diseases; Drevenšek, G., Ed.; IntechOpen: New York, NY, USA, 2017.
  18. Xu, S.; Yu, S.; Dong, D.; Lee, L.T.O. G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer. Front. Endocrinol. 2019, 10, 725.
  19. Notas, G.; Kampa, M.; Castanas, E. G Protein-Coupled Estrogen Receptor in Immune Cells and Its Role in Immune-Related Diseases. Front. Endocrinol. 2020, 11, 579420.
  20. Tonn Eisinger, K.R.; Gross, K.S.; Head, B.P.; Mermelstein, P.G. Interactions between estrogen receptors and metabotropic glutamate receptors and their impact on drug addiction in females. Horm. Behav. 2018, 104, 130–137.
  21. Meitzen, J.; Mermelstein, P.G. Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J. Chem. Neuroanat. 2011, 42, 236–241.
  22. Zárate, S.; Stevnsner, T.; Gredilla, R. Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair. Front. Aging Neurosci. 2017, 9, 430.
  23. Nalvarte, I. Sex Stratified Treatment of Neurological Disorders: Challenges and Perspectives. Brain Sci. 2020, 10, 103.
  24. Schmidt, R.; Kienbacher, E.; Benke, T.; Dal-Bianco, P.; Delazer, M.; Ladurner, G.; Jellinger, K.; Marksteiner, J.; Ransmayr, G.; Schmidt, H.; et al. Geschlechtsspezifische Unterschiede der Alzheimer Demenz . Neuropsychiatry 2008, 22, 1–15.
  25. Beam, C.R.; Kaneshiro, C.; Jang, J.Y.; Reynolds, C.A.; Pedersen, N.L.; Gatz, M. Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer’s Disease. J. Alzheimer’s Dis. 2018, 64, 1077–1083.
  26. Mielke, M.M. Sex and Gender Differences in Alzheimer’s Disease Dementia. Psychiatr. Times 2018, 35, 14–17.
  27. Eliot, L. Neurosexism: The myth that men and women have different brains. Nature 2019, 566, 453–454.
  28. Angelopoulou, G.; Meier, E.L.; Kasselimis, D.; Pan, Y.; Tsolakopoulos, D.; Velonakis, G.; Karavasilis, E.; Kelekis, N.L.; Goutsos, D.; Potagas, C.; et al. Investigating Gray and White Matter Structural Substrates of Sex Differences in the Narrative Abilities of Healthy Adults. Front. Neurosci. 2020, 13, 1424.
  29. Andrew, M.K.; Tierney, M.C. The puzzle of sex, gender and Alzheimer’s disease: Why are women more often affected than men? Women’s Health 2018, 14, 1745506518817995.
  30. Ferretti, M.T.; Iulita, M.F.; Cavedo, E.; Chiesa, P.A.; Schumacher Dimech, A.; Santuccione Chadha, A.; Baracchi, F.; Girouard, H.; Misoch, S.; Giacobini, E.; et al. Sex differences in Alzheimer disease—the gateway to precision medicine. Nat. Rev. Neurol. 2018, 14, 457–469.
  31. Viña, J.; Lloret, A. Why women have more Alzheimer’s disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide. J. Alzheimers Dis. 2010, 20 (Suppl. S2), 527–533.
  32. Martínez Pinto, J.; Castillo, R.L.; Sotomayor-Zárate, R. Sex Hormones: Role in Neurodegenerative Diseases and Addiction, Sex Hormones in Neurodegenerative Processes and Diseases; Drevenšek, G., Ed.; IntechOpen: New York, NY, USA, 2017.
  33. Janicki, S.C.; Schupf, N. Hormonal Influences on Cognition and Risk for Alzheimer’s Disease. Curr. Neurol. Neurosci. Rep. 2010, 10, 359–366.
  34. Gabelli, G.; Codemo, A. Gender differences in cognitive decline and Alzheimer’s disease. Ital. J. Gend.-Specif. Med. 2015, 1, 21–28.
  35. Toro, C.A.; Zhang, L.; Cao, J.; Cai, D. Sex differences in Alzheimer’s disease: Understanding the molecular impact. Brain Res. 2019, 1719, 194–207.
  36. Bangasser, D.; Dong, H.; Carroll, J.; Plona, Z.; Ding, H.; Rodriguez, L.; McKennan, C.; Csernansky, J.G.; Seeholzer, S.H.; Valentino, R.J. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer’s disease-related signaling. Mol. Psychiatry 2016, 22, 1126–1133.
  37. Zagni, E.; Simoni, L.; Colombo, D. Sex and Gender Differences in Central Nervous System-Related Disorders. Neurosci. J. 2016, 2016, 1–13.
  38. Jurado-Coronel, J.C.; Cabezas, R.; Ávila Rodríguez, M.F.; Echeverria, V.; García-Segura, L.M.; Barreto, G.E. Sex differences in Park-inson′s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics. Front. Neuroendocrinol. 2018, 50, 18–30.
  39. Buck, S.A.; Steinkellner, T.; Aslanoglou, D.; Villeneuve, M.; Bhatte, S.H.; Childers, V.C.; Rubin, S.A.; De Miranda, B.R.; O’Leary, E.I.; Neureiter, E.G.; et al. Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age-related neurodegeneration. Aging Cell 2021, 20, e13365.
  40. Gillies, G.E.; Pienaar, I.S.; Vohra, S.; Qamhawi, Z. Sex differences in Parkinson’s disease. Front. Neuroendocrinol. 2014, 35, 370–384.
  41. Cerri, S.; Mus, L.; Blandini, F. Parkinson’s Disease in Women and Men: What’s the Difference? J. Parkinsons Dis. 2019, 9, 501–515.
  42. Hassin-Baer, S.; Molchadski, I.; Cohen, O.S.; Nitzan, Z.; Efrati, L.; Tunkel, O.; Kozlova, E.; Korczyn, A.D. Gender effect on time to levodopa-induced dyskinesias. J. Neurol. 2011, 258, 2048–2053.
  43. Beghi, E.; Beghi, M. Gender Difference in Epidemiology and Comorbidities of Epilepsy. In Epilepsy in Women; John Wiley and Sons: Hoboken, NJ, USA, 2013; pp. 1–10.
  44. McHugh, J.C.; Delanty, N. Epidemiology and classification of epilepsy: Gender comparisons. Int. Rev. Neurobiol. 2008, 83, 11–26.
  45. Kishk, N.; Mourad, H.; Ibrahim, S. Sex differences among epileptic patients: A comparison of epilepsy and its impacts on demographic features, clinical characteristics, and management patterns in a tertiary care hospital in Egypt. Egypt J. Neurol Psychiatry Neurosurg. 2019, 55, 39.
  46. Christensen, J.; Kjeldsen, M.J.; Andersen, H.; Friis, M.L.; Sidenius, P. Gender Differences in Epilepsy. Epilepsia 2005, 46, 956–960.
  47. Reddy, D.S.; Thompson, W.; Calderara, G. Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis. Neurosci. Lett. 2021, 750, 135753.
  48. Joshi, S.; Kapur, J. Neurosteroid regulation of GABAA receptors: A role in catamenial epilepsy. Brain Res. 2019, 1703, 31–40.
  49. Mazdeh, M.; Heidari, M.; Taheri, M.; Ghafouri-Fard, S. Anticonvulsant drugs effects on sex hormone levels and sexual function in men with epilepsy. Future Neurol. 2020, 15, 2.
  50. Verrotti, A.; D’Egidio, C.; Mohn, A.; Coppola, G.; Parisi, P.; Chiarelli, F. Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 2011, 52, 199–211.
  51. Fisher, A.D.; Ristori, J.; Maggi, M. Pharmachosexology: Use of Sex Hormones in Psychiatric Conditions. Sex. Dysfunct. Ment. Ill Patients 2018, 215–224.
  52. Slavich, G.M.; Sacher, J. Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Trans-duction Theory of Depression to account for sex differences in mood disorders. Psychopharmacology 2019, 236, 3063–3079.
  53. Morssinkhof, M.; van Wylick, D.; Priester-Vink, S.; van der Werf, Y.; Heijer, M.D.; Heuvel, O.V.D.; Broekman, B. Associations between sex hormones, sleep problems and depression: A systematic review. Neurosci. Biobehav. Rev. 2020, 118, 669–680.
  54. Young, E.; Korszun, A. Sex, trauma, stress hormones and depression. Mol. Psychiatry 2009, 15, 23–28.
  55. Soares, C.N.; Zitek, B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability? J. Psychiatry Neurosci. 2008, 33, 331–343.
  56. Hwang, W.J.; Lee, T.Y.; Kim, N.S.; Kwon, J.S. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. Int. J. Mol. Sci. 2020, 22, 373.
  57. Hernández-Hernández, O.T.; Mota, L.A.M.; Herrera-Pérez, J.J.; Jiménez-Rubio, G. Role of Estradiol in the Expression of Genes Involved in Serotonin Neurotransmission: Implications for Female Depression. Curr. Neuropharmacol. 2019, 17, 459–471.
  58. Klein, S.L.; Flanagan, K.L. Sex differences in immune responses. Nat. Rev. Immunol. 2016, 16, 626–638.
  59. Bianca, C.; Delitala, M. On the modelling of genetic mutations and immune system competition. Comput. Math. Appl. 2011, 61, 2362–2375.
  60. Nowak, J.; Pawlowski, B.; Borkowska, B.; Augustyniak, D.; Drulis-Kawa, Z. No evidence for the immunocompetence handicap hypothesis in male humans. Sci. Rep. 2018, 8, 7392.
  61. Roved, J.; Westerdahl, H.; Hasselquist, D. Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences. Horm. Behav. 2017, 88, 95–105.
  62. Rettew, J.A.; Huet-Hudson, Y.M.; Marriott, I. Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity. Biol. Reprod. 2008, 78, 432–437.
  63. Maggio, M.; Basaria, S.; Ceda, G.P.; Ble, A.; Ling, S.M.; Bandinelli, S.; Valenti, G.; Ferrucci, L. The relationship between testosterone and molecular markers of inflammation in older men. J. Endocrinol. Investig. 2005, 28, 116–119.
  64. Trumble, B.C.; Blackwell, A.D.; Stieglitz, J.; Thompson, M.E.; Suarez, I.M.; Kaplan, H.; Gurven, M. Associations between male testosterone and immune function in a pathogenically stressed forager-horticultural population. Am. J. Phys. Anthropol. 2016, 161, 494–505.
  65. Jaillon, S.; Berthenet, K.; Garlanda, C. Sexual Dimorphism in Innate Immunity. Clin. Rev. Allergy Immunol. 2017, 56, 308–321.
  66. Bouman, A.; Heineman, M.J.; Faas, M.M. Sex hormones and the immune response in humans. Hum. Reprod. Updat. 2005, 11, 411–423.
  67. Taneja, V. Sex Hormones Determine Immune Response. Front. Immunol. 2018, 9, 1931.
  68. Moulton, V.R. Sex Hormones in Acquired Immunity and Autoimmune Disease. Front. Immunol. 2018, 9, 2279.
  69. Desai, M.K.; Brinton, R.D. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front. Endocrinol. 2019, 10, 265.
  70. Lasrado, N.; Jia, T.; Massilamany, C.; Franco, R.; Illes, Z.; Reddy, J. Mechanisms of sex hormones in autoimmunity: Focus on EAE. Biol. Sex Differ. 2020, 11, 50.
  71. Reinhard, G.; Noll, A.; Schlebusch, H.; Mallmann, P.; Ruecker, A.V. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem. Biophys. Res. Commun. 1998, 245, 933–938.
  72. Ortona, E.; Pierdominici, M.; Maselli, A.; Veroni, C.; Aloisi, F.; Shoenfeld, Y. Sex-based differences in autoimmune diseases. Ann. Dell’istituto Super. Sanita 2016, 52, 205–212.
  73. Sparaco, M.; Bonavita, S. The role of sex hormones in women with multiple sclerosis: From puberty to assisted reproductive techniques. Front. Neuroendocr. 2020, 60, 100889.
  74. Romo-García, M.F.; Zapata-Zuñiga, M.; Enciso-Moreno, J.A.; Castañeda-Delgado, J.E. The Role of Estrogens in Rheumatoid Arthritis Physiopathology. Rheum. Arthritis—Other Perspect. Towards a Better Practice. 27 August 2020. Available online: https://www.intechopen.com/chapters/73070 (accessed on 17 November 2021).
  75. Hall, M.D.; Mideo, N. Linking sex differences to the evolution of infectious disease life-histories. Philos. Trans. R. Soc. B Biol. Sci. 2018, 373, 20170431.
  76. Ingersoll, M.A. Sex differences shape the response to infectious diseases. PLOS Pathog. 2017, 13, e1006688.
  77. Van Lunzen, J.; Altfeld, M. Sex Differences in Infectious Diseases-Common but Neglected. J. Infect. Dis. 2014, 209 (Suppl. S3), S79–S80.
  78. Morgan, R.; Klein, S.L. The intersection of sex and gender in the treatment of influenza. Curr. Opin. Virol. 2019, 35, 35–41.
  79. Baden, R.; Rockstroh, J.K.; Buti, M. Natural History and Management of Hepatitis C: Does Sex Play a Role? J. Infect. Dis. 2014, 209, S81–S85.
  80. Girum, T.; Wasie, A.; Lentiro, K.; Muktar, E.; Shumbej, T.; Difer, M.; Shegaze, M.; Worku, A. Gender disparity in epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Arch. Public Health 2018, 76, 1–10.
  81. Caselli, G.; Egidi, V. Gender differences in COVID-19 cases and death rates in Italy. Ital. J. Gend.-Specif. Med. 2020, 6, 96–99.
  82. Abate, B.B.; Kassie, A.M.; Kassaw, M.W. Sex Difference in Coronavirus Disease (COVID-19): A Systematic Review and Me-Ta-Analysis. BMJ Open 2020, 10, e040129.
  83. Naz, M.S.G.; Banaei, M.; Dashti, S.; Tehrani, F.R. An overview of sex hormones in relation to SARS-CoV-2 infection. Future Virol. 2021, 16, 555–564.
  84. Raza, H.A.; Sen, P.; Bhatti, O.A.; Gupta, L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol. Int. 2021, 41, 1375–1386.
  85. Rehman, S.; Ravinayagam, V.; Nahvi, I.; Aldossary, H.; Al-Shammari, M.; Al Amiri, M.S.; Kishore, U.; Al-Suhaimi, E.A. Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women. Front. Immunol. 2021, 12.
  86. Al-Lami, R.A.; Urban, R.J.; Volpi, E.; Algburi, A.M.A.; Baillargeon, J. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19). Mayo Clin. Proc. 2020, 95, 1710–1714.
  87. Ragab, D.; Eldin, H.S.; Taeimah, M.; Khattab, R.; Salem, R. The COVID-19 Cytokine Storm; What We Know So Far. Front. Immunol. 2020, 11, 1446.
  88. Niemann, P.J.; Goldstein, H.V. Testosterone in COVID-19: Friend or Foe? Endocrine 2021, 71, 281–282.
  89. Younis, J.S.; Skorecki, K.; Abassi, Z. The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic. Front. Endocrinol. 2021, 12, 607179.
  90. Moravvej, H.; Pourani, M.R.; Baghani, M.; Abdollahimajd, F. Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens. Dermatol. Ther. 2021, 34, e15004.
  91. Dhindsa, S.; Zhang, N.; McPhaul, M.J.; Wu, Z.; Ghoshal, A.K.; Erlich, E.C.; Mani, K.; Randolph, G.J.; Edwards, J.R.; Mudd, P.A.; et al. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients with COVID-19. JAMA Netw. Open 2021, 4, e2111398.
  92. Hussain, A.N.; Hussain, F.; Hashmi, S.K. Role of testosterone in COVID-19 patients—A double-edged sword? Med. Hypotheses 2020, 144, 110287.
  93. Auerbach, J.M.; Khera, M. Testosterone’s Role in COVID-19. J. Sex. Med. 2021, 18, 843–848.
  94. Spini, A.; Giudice, V.; Brancaleone, V.; Morgese, M.G.; De Francia, S.; Filippelli, A.; Ruggieri, A.; Ziche, M.; Ortona, E.; Cignarella, A.; et al. Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity. Pharmacol. Res. 2021, 173, 105848.
  95. Ong, L.K.; Walker, F.R.; Nilsson, M. Is Stroke a Neurodegenerative Condition? A Critical Review of Secondary Neurodegeneration and Amyloid-beta Accumulation after Stroke. AIMS Med. Sci. 2017, 4, 1–16.
  96. Mosca, L.; Barrett-Connor, E.; Wenger, N.K. Sex/gender differences in cardiovascular disease prevention: What a difference a decade makes. Circulation 2011, 124, 2145–2154.
  97. Regitz-Zagrosek, V.; Kararigas, G. Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol. Rev. 2017, 97, 1–37.
  98. Koellhoffer, E.C.; McCullough, L.D. The Effects of Estrogen in Ischemic Stroke. Transl. Stroke Res. 2012, 4, 390–401.
  99. Manwani, B.; Bentivegna, K.; Benashski, S.E.; Venna, V.R.; Xu, Y.; Arnold, A.P.; McCullough, L.D. Sex Differences in Ischemic Stroke Sensitivity Are Influenced by Gonadal Hormones, Not by Sex Chromosome Complement. J. Cereb. Blood Flow Metab. 2014, 35, 221–229.
  100. Carbone, S.; Canada, J.M.; Billingsley, H.; Siddiqui, M.S.; Elagizi, A.; Lavie, C.J. Obesity paradox in cardiovascular disease: Where do we stand? Vasc. Health. Risk Manag. 2019, 15, 89–100.
  101. Wong, C.; Marwick, T.H. Obesity cardiomyopathy: Pathogenesis and pathophysiology. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4, 436–443.
  102. Mathieu, P.; Lemieux, I.; Després, J.P. Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 2010, 87, 407–416.
  103. Clark, A.L.; Chyu, J.; Horwich, T.B. The Obesity Paradox in Men Versus Women With Systolic Heart Failure. Am. J. Cardiol. 2012, 110, 77–82.
  104. Leeners, B.; Geary, N.; Tobler, P.N.; Asarian, L. Ovarian hormones and obesity. Hum. Reprod. Updat. 2017, 23, 300–321.
  105. Marques, A.; Peralta, M.; Naia, A.; Loureiro, N.; de Matos, M.G. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur. J. Public Health 2017, 28, 295–300.
  106. Modi, N.D.; Tan, J.Q.E.; Rowland, A.; Koczwara, B.; Abuhelwa, A.Y.; Kichenadasse, G.; McKinnon, R.A.; Wiese, M.D.; Sorich, M.J.; Hopkins, A.M. The obesity paradox in early and advanced HER2 positive breast cancer: Pooled analysis of clinical trial data. NPJ Breast Cancer 2021, 7, 1–6.
  107. Mair, K.M.; Gaw, R.; MacLean, M.R. Obesity, estrogens and adipose tissue dysfunction—Implications for pulmonary arterial hypertension. Pulm. Circ. 2020, 10, 2045894020952019.
  108. Aronica, L.; Rigdon, J.; Offringa, L.C.; Stefanick, M.L.; Gardner, C.D. Examining differences between overweight women and men in 12-month weight loss study comparing healthy low-carbohydrate vs. low-fat diets. Int. J. Obes. 2020, 45, 225–234.
  109. Man, J.J.; Beckman, J.A.; Jaffe, I.Z. Sex as a Biological Variable in Atherosclerosis. Circ. Res. 2020, 126, 1297–1319.
  110. Spence, J.D.; Pilote, L. Importance of sex and gender in atherosclerosis and cardiovascular disease. Atherosclerosis 2015, 241, 208–210.
  111. Mathur, P.; Ostadal, B.; Romeo, F.; Mehta, J.L. Gender-Related Differences in Atherosclerosis. Cardiovasc. Drugs Ther. 2015, 29, 319–327.
  112. Fairweather, D. Sex differences in inflammation during atherosclerosis. Clin. Med. Insights Cardiol. 2014, 8, 49–59.
  113. Ramirez, L.A.; Sullivan, J.C. Sex Differences in Hypertension: Where We Have Been and Where We Are Going. Am. J. Hypertens. 2018, 31, 1247–1254.
  114. Dunne, F.P.; Barry, D.G.; Ferriss, J.B.; Grealy, G.; Murphy, D. Changes in blood pressure during the normal menstrual cycle. Clin. Sci. (Lond.) 1991, 81, 515–518.
  115. Gillis, E.E.; Sullivan, J.C. Sex Differences in Hypertension: Recent Advances. Hypertension 2016, 68, 1322–1327.
  116. Lam, C.S.P.; Arnott, C.; Beale, A.L.; Chandramouli, C.; Hilfiker-Kleiner, D.; Kaye, D.M.; Ky, B.; Santema, B.T.; Sliwa, K.; Voors, A.A. Sex differences in heart failure. Eur. Heart J. 2019, 40, 3859–3868.
  117. Savarese, G.; D’Amario, D. Sex Differences in Heart Failure. Adv. Exp. Med. Biol. 2018, 1065, 529–544.
  118. Strömberg, A.; Mårtensson, J. Gender Differences in Patients with Heart Failure. Eur. J. Cardiovasc. Nurs. 2003, 2, 7–18.
  119. Bozkurt, B.; Khalaf, S. Heart Failure in Women. Methodist Debakey Cardiovasc. J. 2017, 13, 216–223.
  120. Regitz-Zagrosek, V. Sex and Gender Differences in Heart Failure. Int. J. Hear. Fail. 2020, 2, 157.
  121. Lopes-Ramos, C.M.; Quackenbush, J.; DeMeo, D.L. Genome-Wide Sex and Gender Differences in Cancer. Front. Oncol. 2020, 10, 597788.
  122. Dorak, M.T.; Karpuzoglu, E. Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue. Front. Genet. 2012, 3, 268.
  123. Cook, M.B.; McGlynn, K.A.; Devesa, S.S.; Freedman, N.D.; Anderson, W.F. Sex Disparities in Cancer Mortality and Survival. Cancer Epidemiol. Biomark. Prev. 2011, 20, 1629–1637.
  124. Wagner, A.; Oertelt-Prigione, S.; Adjei, A.; Buclin, T.; Cristina, V.; Csajka, C.; Coukos, G.; Dafni, U.; Dotto, G.-P.; Ducreux, M.; et al. Gender medicine and oncology: Report and consensus of an ESMO workshop. Ann. Oncol. 2019, 30, 1914–1924.
  125. Singmann, P.; Shem-Tov, D.; Wahl, S. Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics Chromatin. 2015, 8, 43.
  126. Peng, Y.; Wu, Q.; Wang, L.; Wang, H.; Yin, F. A DNA methylation signature to improve survival prediction of gastric cancer. Clin. Epigenetics 2020, 12, 15.
  127. Wang, S.; Cowley, L.A.; Liu, X.-S. Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy. Molecules 2019, 24, 3214.
  128. Zhu, Y.; Shao, X.; Wang, X.; Liu, L.; Liang, H. Sex disparities in cancer. Cancer Lett. 2019, 466, 35–38.
  129. Caputo, V.; Raffaella Cascella, R.; Strafella, C. Gender and complex diseases: Insights into sex-specific epigenetics. Genere e malattie complesse: Meccanismi epigenetici sesso-specifici. Ital. J. Gend.-Specif. Med. 2018, 4, 108–113.
  130. Stapelfeld, C.; Dammann, C.; Maser, E. Sex-specificity in lung cancer risk. Int. J. Cancer. 2020, 146, 2376–2382.
  131. Olak, J.; Colson, Y. Gender differences in lung cancer: Have we really come a long way, baby? J. Thorac Cardiovasc. Surg. 2004, 128, 346–351.
  132. Hansen, M.S.; Licaj, I.; Braaten, T.; Langhammer, A.; Le Marchand, L.; Gram, I.T. Sex Differences in Risk of Smoking-Associated Lung Cancer: Results From a Cohort of 600,000 Norwegians. Am. J. Epidemiol. 2017, 187, 971–981.
  133. Zdemir, B.C.; Csajka, C.; Dotto, G.P.; Wagner, A.D. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Under-valued Issue in the Era of Precision Oncology. J. Clin. Oncol. 2018, 36, 2680–2683.
  134. Schmetzer, O.; Flörcken, A. Sex Differences in the Drug Therapy for Oncologic Diseases. Sex Gend. Differ. Pharmacol. 2012, 214, 411–442.
  135. Ulm, M.; Ramesh, A.V.; McNamara, K.M.; Ponnusamy, S.; Sasano, H.; Narayanan, R. Therapeutic advances in hormone-dependent cancers: Focus on prostate, breast and ovarian cancers. Endocr. Connect. 2019, 8, R10–R26.
  136. Carè, A.; Bellenghi, M.; Matarrese, P.; Gabriele, L.; Salvioli, S.; Malorni, W. Sex disparity in cancer: Roles of microRNAs and related functional players. Cell Death Differ. 2018, 25, 477–485.
  137. Collier, V.; Musicante, M.; Patel, T.; Liu-Smith, F. Sex disparity in skin carcinogenesis and potential influence of sex hormones. Skin Health Dis. 2021, 1, e27.
  138. Dika, E.; Patrizi, A.; Lambertini, M.; Manuelpillai, N.; Fiorentino, M.; Altimari, A.; Ferracin, M.; Lauriola, M.; Fabbri, E.; Campione, E.; et al. Estrogen Receptors and Melanoma: A Review. Cells 2019, 8, 1463.
  139. Rubin, J.B.; Lagas, J.S.; Broestl, L.; Sponagel, J.; Rockwell, N.; Rhee, G.; Rosen, S.F.; Chen, S.; Klein, R.S.; Imoukhuede, P.; et al. Sex differences in cancer mechanisms. Biol. Sex Differ. 2020, 11, 17.
  140. Berner, A.M. Improving understanding of cancer in the gender diverse population. Nat. Cancer 2021, 21, 537–538.
  141. Matarrese, P.; Mattia, G.; Pagano, M.; Pontecorvi, G.; Ortona, E.; Malorni, W.; Carè, A. The Sex-Related Interplay between TME and Cancer: On the Critical Role of Estrogen, MicroRNAs and Autophagy. Cancers 2021, 13, 3287.
  142. Payne, S. Gender in Lung Cancer and Smoking Research; World Health Organization: Albany, NY, USA, 2004.
  143. Liu-Smith, F.; Farhat, A.M.; Arce, A.; Ziogas, A.; Taylor, T.; Wang, Z.; Yourk, V.; Liu, J.; Wu, J.; McEligot, A.J.; et al. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure. J. Am. Acad. Dermatol. 2016, 76, 499–505.e3.
  144. Yu, C.; Wong, E.; Joo, J.; Hodge, A.; Makalic, E.; Schmidt, D.; Buchanan, D.; Severi, G.; Hopper, J.; English, D.; et al. Epigenetic Drift Association with Cancer Risk and Survival, and Modification by Sex. Cancers 2021, 13, 1881.
  145. Dunford, A.; Weinstock, D.M.; Savova, V.; Schumacher, S.E.; Cleary, J.P.; Yoda, A.; Sullivan, T.J.; Hess, J.M.; Gimelbrant, A.A.; Beroukhim, R.; et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 2016, 49, 10–16.
  146. Rizzolo, P.; Silvestri, V.; Tommasi, S.; Pinto, R.; Danza, K.; Falchetti, M.; Gulino, M.; Frati, P.; Ottini, L. Male breast cancer: Genetics, epigenetics, and ethical aspects. Ann Oncol. 2013, 24 (Suppl. S8), 75–82.
  147. Craig, J.M.; Turner, T.H.; Harrell, J.C.; Clevenger, C.V. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer. Endocrinology 2021, 162, bqab036.
  148. Grible, J.M.; Zot, P.; Olex, A.L.; Hedrick, S.E.; Harrell, J.C.; Woock, A.E.; Idowu, M.O.; Clevenger, C.V. The human intermediate prolactin receptor is a mammary proto-oncogene. NPJ Breast Cancer 2021, 7, 37.
  149. Novelli, G. Epigenetics and gender. Epigenetica e genere. Ital. J. Gend.-Specif. Med. 2017, 3, 139–140.
  150. Suderman, M.; Simpkin, A.; Sharp, G.; Gaunt, T.R.; Lyttleton, O.; McArdle, W.; Ring, S.; Smith, G.D.; Relton, C. Sex-associated autosomal DNA methylation differences are wide-spread and stable throughout childhood. Biorxiv 2017, 118265.
  151. Sarne, V.; Braunmueller, S.; Rakob, L.; Seeboeck, R. The Relevance of Gender in Tumor-Influencing Epigenetic Traits. Epigenomes 2019, 3, 6.
  152. Lin, S.; Liu, Y.; Goldin, L.R.; Lyu, C.; Kong, X.; Zhang, Y.; Caporaso, N.E.; Xiang, S.; Gao, Y. Sex-related DNA methylation differences in B cell chronic lymphocytic leukemia. Biol. Sex Differ. 2019, 10, 2.
  153. Hall, E.; Volkov, P.; Dayeh, T.; Esguerra, J.L.S.; Salö, S.; Eliasson, L.; Rönn, T.; Bacos, K.; Ling, C. Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets. Genome Biol. 2014, 15, 522.
  154. Ye, Y.; Jing, Y.; Li, L.; Mills, G.B.; Diao, L.; Liu, H.; Han, L. Sex-associated molecular differences for cancer immunotherapy. Nat. Commun. 2020, 11, 1779.
  155. Irelli, A.; Sirufo, M.M.; D’Ugo, C.; Ginaldi, L.; De Martinis, M. Sex and Gender Influences on Cancer Immunotherapy Response. Biomedicines 2020, 8, 232.
  156. Wagner, A.D. Sex Differences in Cancer Chemotherapy Effects, and Why We Need to Reconsider BSA-Based Dosing of Chemo-Therapy. ESMO Open 2020, 5, e000770.
  157. Kim, H.-I.; Lim, H.; Moon, A. Sex Differences in Cancer: Epidemiology, Genetics and Therapy. Biomol. Ther. 2018, 26, 335–342.
More
Video Production Service